☆ 3.8 Article

Is there a difference between GBS triggered by COVID-19 and those of other origins?

EGYPTIAN JOURNAL OF NEUROLOGY PSYCHIATRY AND NEUROSURGERY (2022)

Related references

Note: Only part of the references are listed.

Review Clinical Neurology

Guillain-Barre syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases

Samir Abu-Rumeileh et al.

Summary: This study systematically reviewed 73 cases of GBS associated with COVID-19 reported in publications until July 2020. Most patients developed GBS manifestations after COVID-19 infection, with a majority showing good prognosis, and a male predominance was observed.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome

Stephen Keddie et al.

Summary: This study did not find any causal relationship between COVID-19 and GBS, and the incidence of GBS decreased during the pandemic, potentially due to lockdown measures reducing transmission of pathogens that induce GBS.

BRAIN (2021)

Add to Collection

Review Infectious Diseases

A Comprehensive Systematic Review of CSF analysis that defines Neurological Manifestations of COVID-19

Medha Tandon et al.

Summary: Limited literature exists on Cerebrospinal fluid (CSF) findings in COVID-19 patients with neurological symptoms. Analysis of 113 patients showed elevated CSF protein levels in fatal cases and higher CSF protein and cell counts in severe cases. Further studies on the pathophysiology of neurological complications in COVID-19 are recommended.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Review Clinical Neurology

Is Guillain-Barre Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence

Auwal Abdullahi et al.

Summary: This review investigated the association between GBS and COVID-19 infection. Fifty-one high-quality studies were included, with the majority of patients having confirmed diagnosis of COVID-19 and GBS diagnosis based on standard clinical, electrophysiological, and cerebrospinal fluid criteria. Testing for COVID-19 is recommended in patients presenting with GBS during the pandemic.

FRONTIERS IN NEUROLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Guillain-Barre syndrome

Nortina Shahrizaila et al.

Summary: Guillain-Barre syndrome is the most common cause of acute flaccid paralysis worldwide and is associated with various microorganisms. While most patients recover well with immunotherapy, some may be left with disabilities or even die. International collaborative studies are currently conducting clinical trials to develop more effective treatments for this syndrome.

LANCET (2021)

Add to Collection

Article Clinical Neurology

Guillain-Barre syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions

Massimiliano Filosto et al.

Summary: During the COVID-19 outbreak in northern Italy, there was a significant increase in GBS incidence, with COVID-19-associated GBS being predominantly demyelinating and more severe, leading to higher rates of ICU admission.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Add to Collection

Article Clinical Neurology

Modulation of Nogo receptor 1 expression orchestrates myelin-associated infiltration of glioblastoma

Jun-Hee Hong et al.

Summary: The study identified NgR1 as a key player in suppressing myelin-associated infiltration in glioblastoma cells, suggesting that reactivating NgR1 expression may improve the clinical outcome of glioblastoma patients by inhibiting aggressive infiltration.

BRAIN (2021)

Add to Collection

Article Clinical Neurology

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barre syndrome

Stephen Keddie et al.

Summary: Reports of Guillain-Barre syndrome during the COVID-19 pandemic did not show a causative association between COVID-19 and GBS. The incidence of GBS decreased during the pandemic, potentially due to lockdown measures reducing transmission of GBS-inducing pathogens. Intubation was more common in GBS cases with COVID-19, attributed to pulmonary involvement.

BRAIN (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2

Xi Xu et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)

Add to Collection

Editorial Material Medicine, General & Internal

A novel coronavirus outbreak of global health concern

Chen Wang et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Letter Clinical Neurology

Guillain-Barre syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Hua Zhao et al.

LANCET NEUROLOGY (2020)

Add to Collection

Review Clinical Neurology

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review

Muhammad Umer Ahmed et al.

FRONTIERS IN NEUROLOGY (2020)

Add to Collection

Review Clinical Neurology

Guillain-Barre syndrome associated with SARS-CoV-2 infection. A systematic review

P. De Sanctis et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Add to Collection

Editorial Material Clinical Neurology

Guillain-Barre syndrome in times of pandemics

Sonja E. Leonhard et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Add to Collection

Review Clinical Neurology

Central nervous system manifestations of COVID-19: A systematic review

Ali A. Asadi-Pooya et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Add to Collection

Article Clinical Neurology

COVID-19-associated Guillain-Barresyndrome: The early pandemic experience

James B. Caress et al.

MUSCLE & NERVE (2020)

Add to Collection

Article Clinical Neurology

COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation

Duraisamy Kempuraj et al.

NEUROSCIENTIST (2020)

Add to Collection

Letter Infectious Diseases

Positive RT-PCR nasopharyngeal swab in patients recovered from COVID-19 disease: When does quarantine really end?

Francesco Landi et al.

JOURNAL OF INFECTION (2020)

Add to Collection

Review Clinical Neurology

Guillain-Barre syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic

Antonino Uncini et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Add to Collection

Article Clinical Neurology

Incidence and mortality rates ofGuillain-Barresyndrome in Serbia

Aleksandar Stojanov et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2020)

Add to Collection

Article Clinical Neurology

Neuromuscular presentations in patients with COVID-19

Vimal Kumar Paliwal et al.

NEUROLOGICAL SCIENCES (2020)

Add to Collection

Article Clinical Neurology

Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome

Harry Alexopoulos et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Add to Collection

Letter Critical Care Medicine

Medical Research Council-sumscore: a tool for evaluating muscle weakness in patients with post-intensive care syndrome

Zeynep Turan et al.

CRITICAL CARE (2020)

Add to Collection

Review Clinical Neurology

Diagnosis and management of Guillain-Barre syndrome in ten steps

Sonja E. Leonhard et al.

NATURE REVIEWS NEUROLOGY (2019)

Add to Collection

Article Clinical Neurology

Regional variation of Guillain-Barre syndrome

Alex Y. Doets et al.

BRAIN (2018)

Add to Collection

Review Clinical Neurology

The electrodiagnosis of Guillain-Barre syndrome subtypes: Where do we stand?

Antonino Uncini et al.

CLINICAL NEUROPHYSIOLOGY (2018)

Add to Collection

Article Clinical Neurology

Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria

Christiaan Fokke et al.

BRAIN (2014)

Add to Collection

Review Public, Environmental & Occupational Health

Population Incidence of Guillain-Barre Syndrome: A Systematic Review and Meta-Analysis

James J. Sejvar et al.

NEUROEPIDEMIOLOGY (2011)

Add to Collection

Article Immunology

Guillain-Barre syndrome and Fisher syndrome: Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

James J. Sejvar et al.

VACCINE (2011)

Add to Collection

Article Clinical Neurology

A clinical prognostic scoring system for Guillain-Barre syndrome

Rinske van Koningsveld et al.

LANCET NEUROLOGY (2007)

Add to Collection

© Peeref 2019-2024. All rights reserved.